Occurrence of pulmonary rheumatoid nodules following biological therapies
Abstract
In rheumatoid arthritis (RA), disease activity is generally determined by the joint involvement, but the treatment outcome is often influenced by extra-articular manifestations. Authors present a 74-year-old female patient’s case history, who was treated with seropositive RA. Marked disease activity was observed even following combined traditional disease-modifying antirheumatic drug (DMARD) treatment (disease activity score in 28 joints (DAS28) = 6.6). Therefore, the patient received TNF-α antagonist therapy. Golimumab was administered subcutaneous (SC) once monthly which resulted in significant improvement in both clinical and laboratory signs (DAS28 = 3:43). However, the follow-up chest x-ray indicated multiple intrapulmonary foci and enlarged lymph nodes. Biopsies and histology excluded malignancy; rheumatoid nodules were confirmed. Anti-TNF therapy was discontinued and tocilizumab treatment was initiated. The IL-6 receptor inhibitor suppressed arthritic activity, and 2 months later, the follow-up chest x-ray showed a regression of chest nodules. Our cases, as well as reports from other centers, suggest that TNF blockade may induce rheumatoid nodulosis and the use of alternative biologics may be feasible as further treatment of RA.
Keywords
Golimumab Pulmonary rheumatoid nodules Rheumatoid arthritis TNF-α inhibitor TocilizumabNotes
Acknowledgments
The work was supported by the European Union and the State of Hungary co-financed by the European Social Fund in the framework of TÁMOP-4.2.4.A/2-11/1-2012-0001 ‘National Excellence Program’ (Z.S.)
Disclosures
None
References
- 1.Myasoedova E, Davis JM, Crowson CS, Gabriel SE (2010) Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. Curr Rheumatol Rep 12:379–385CrossRefPubMedGoogle Scholar
- 2.Kerstens P, Boerbooms AM, Jeurissen ME et al (1992) Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis; an analysis of ten cases. J Rheumatol 19:867–71PubMedGoogle Scholar
- 3.Braun MG, Van Rhee R, Becker-Capeller D (2004) Development and/or increase of rheumatoid nodules in rheumatoid arthritis patients following leflunomide therapy. Rheumatology 63:84–87Google Scholar
- 4.Kekow J, Welte T, Kellner U et al (2002) Development of rheumatoid nodules during anti-ecrosis factor alpha therapy with etanercept. Arthritis Rheum 46:843–844CrossRefPubMedGoogle Scholar
- 5.Toussirot E, Berthelot JM, Pertuiset E et al (2009) Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor alpha-blocking agent: a case series. J Rheumatol 36:2421–2427CrossRefPubMedGoogle Scholar
- 6.Khurana R, Wolf R, Berney S (2008) Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans. J Rheum 35:1704–1708PubMedGoogle Scholar
- 7.Smitten AL, Simon TA, Hochberg MC et al (2008) A metaanalysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 10:R45PubMedCentralCrossRefPubMedGoogle Scholar
- 8.Saraya T, Tanaka R, Fujiwara M et al (2013) Fluorodeoxyglucose (FDG) uptake in pulmonary rheumatoid nodules diagnosed by video-assisted thoracic surgery lung biopsy: two case reports and a review of the literature. Mod Rheumatol 23:393–396CrossRefPubMedGoogle Scholar
- 9.Spina D, Ambrosio MR, Rocca BJ et al (2011) Rheumatoid nodule and combined pulmonary carcinoma: topographic correlations; a case report and review of the literature. Histol Histopathol 26:351–356PubMedGoogle Scholar
- 10.Derot G, Marini-Portugal A, Maitre B et al (2009) Marked regression of pulmonary rheumatoid nodules under etanercept therapy. J Rheumatol 36:437–439CrossRefPubMedGoogle Scholar
- 11.Andres M, Vela P, Romera C (2012) Marked improvement of lung rheumatoid nodules after treatment with tocilizumab. Rheumatology 51:1132–1134CrossRefPubMedGoogle Scholar
- 12.Glace B, Gottenberg JE, Mariette X et al (2012) Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French Auto Immunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry). Ann Rheum Dis 71:1429–1431CrossRefPubMedGoogle Scholar